Programa de Neuroimmunología - IDIBAPS

Notícies

II Update on Optic Nerve Degeneration. A European Network. 17-18 March 2017, Barcelona, Spain

PROGRAM 17 MARCH 2017

DOWNLOAD PDF

 
 

08:00-09:00

ACCREDITATION

09:00-09:30

CONGRESS OPENING

OPTIC NERVE IN PRIMARY NEURODEGENERATIVE DISORDERS
Chairpersons: Philipp Albrecht & Piero Barboni

09:30-09:50

APOSTEL: consensus recommendations for reporting of quantitative optical coherence tomography study results
Philipp Albrecht

09:50-10:10

Visual afferent damage in patients with REM Behavior Disorder
Ana I Tercero-Uribe

10:10-10:40

New insights into Parkinson's disease and eye 
Alexander U Brandt

10:40-11:10

The eye: a window to the brain also for Alzheimer's Disease?
Luis E Pablo

11:10-11:40

COFFEE BREAK

11:40-12:10

KEYNOTE LECTURE
Immune-mediated disorders involving retina and optic nerve
Francesc Graus

SYMPOSIUM BIOGEN
Neuroprotection in MS: Targeting inflammatory activity effectively from the onset
Elena H Martinez-Lapiscina & Pablo Villoslada

12:10-12:40

The complex relationship between neurodegeneration, demyelination and inflammation: influence in the clinical outcome
Pablo Villoslada

12:40-13:10

Targeting inflammation from the onset: evidences from studies focused on the damage through the visual afferent pathway
Elena H Martinez-Lapiscina

13:10-14:10

LUNCH BREAK

OPTIC NERVE IN IMMUNE-MEDIATED NEURODEGENERATIVE DISORDERS 
Chairpersons: Elena H Martinez-Lapiscina & Giancarlo Comi

14:10-14:30

Visual assessment in clinical practice in MS and NMOSD
Bernardo Sanchez-Dalmau

14:30-14:50

Optic neuritis in NMOSD
Maria Sepúlveda

14:50-15:10

CROCTINO Study: towards clinical advances in NMOSD
Hanna Zimmermann

15:10-15:30

Role of demyelination in MS: VEP as surrogate outcome to measure myelin repair strategies in MS
Letizia Leocani

ACUTE OPTIC NEURITIS AS A PARADIGM FOR PHASE II RCT IN MS AND NMOSD 
Chairpersons: Bernardo Sanchez-Dalmau & Letizia Leocani

15:30-15:50

Natural history of acute optic neuritis
Jette Frederiksen

15:50-16:20

Remyelination and Neuroprotection strategy
Pablo Villoslada

16:20-16:30

Meta-analyses in AON trial: towards a standardization of outcomes
Elena H Martinez-Lapiscina

PRE-PROGRAM 18 MARCH 2017

GLAUCOMA
Chairpersons: Augusto Azuara-Blanco & Francesca Cordeiro

09:00-09:30

KEYNOTE LECTURE
Evaluating the effectiveness of novel interventions for glaucoma. Methodology and design of randomised controlled trials
Augusto Azuara-Blanco

09:30-09:50

The lamina cribrosa as the primary site of glaucoma damage
Gema Rebolleda

09:50-10:10

Neuroprotection in Glaucoma: Current strategies and future directions
Francesca Cordeiro

10:10-10:40

Surgery for Glaucoma
Maribel Canut

SYMPOSIUM OPKO HEALTH SPAIN
José Álvarez Sabín

10:40-11:10

Neuroprotective and neuroregenerative properties of citicoline: an opportunity for ocular neurodegenerative pathologies
José Álvarez Sabín

11:10-11:30

COFFEE BREAK

HEREDITARY OPTIC NERVE DISORDERS
Chairperson: Valerio Carelli & Thomas Klopstock

11:30-11:50

Management of patients with suspicious of hereditary optic nerve disorders
Carmen Ayuso

11:50-12:05

Pediatric hereditary optic neuropathies
Marta Galdós

12:05-12:25

New frontiers on vascular supply in hereditary optic neuropathy
Piero Barboni

12:25-12:40

Inherited optic neuropathy: enlarging the genetic landscape
Valerio Carelli

12:40-13:00

Update on dominant optic atrophy
Marcela Votruba

SYMPOSIUM SANTHERA
Leber's Hereditary Optic Neuropathy (LHON): What to do today in terms of diagnosis and patient management
Gema Rebolleda

13:00-13:15

Chairman introduction
Gema Rebolleda

13:15-13:30

Understanding of the disease and early diagnosis
Bernardo Sanchez-Dalmau

13:30-13:45

Patients Care: Raxone, the new treatment option for LHON´s patients
Thomas Klopstock

13:45-14:15

LUNCH BREAK

IMMUNE MEDIATED OPTIC NEUROPATHIES
Chairpersons: Bernardo Sánchez-Dalmau & Jérôme de Sèze

14:15-14:40

Immune-mediated optic neuropathies: RION and CRION
Jérôme de Sèze

14:40-14:55

Role of GQ1b R in optic nerve
Marianna Spatola

14:55-15:10

Role of GlyR in optic nerve
Eugenia Martinez Hernández

INNOVATION FOR RETINAL AND OPTIC NERVE ASSESSMENT 
Chairpersons: Pablo Loza & Alexander U Brandt

15:10-15:30

New devices for retinal and optic nerve assessment
Brian Fernández

15:30-15:50

Optic properties of retinal structural imaging by optical coherence tomography
Delia DeBuc

15:50-16:10

New optic-based technologies to evaluate retinal damage
David Merino

16:10-16:30

New approaches for mfVEP signal analyses
Luis de Santiago Rodrigo

16:30

CLOSING REMARK